BBHC
COLL icon

Brown Brothers Harriman & Co’s Collegium Pharmaceutical COLL Stock Holding History

Brown Brothers Harriman & Co’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Sell
30
-213
-88% -$7.28K ﹤0.01% 1764
2026
Q1 		$8.04K Hold
243
– – ﹤0.01% 1395
2025
Q4 		$11.3K Hold
243
– – ﹤0.01% 1311
2025
Q3 		$8.5K Buy
+243
New +$8.45K ﹤0.01% 1311

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Brown Brothers Harriman & Co's COLL Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Collegium Pharmaceutical (COLL) stake by 88% in Q2 2026, selling an estimated $7.28K and leaving 30 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Brown Brothers Harriman & Co first reported a position in COLL in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.3K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Brown Brothers Harriman & Co held 30 shares of Collegium Pharmaceutical worth $1.09K as of Q2 2026.
  • Brown Brothers Harriman & Co sold 213 Collegium Pharmaceutical shares in Q2 2026, an estimated $7.28K.
  • Collegium Pharmaceutical made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1764 holding.
  • Brown Brothers Harriman & Co first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • Brown Brothers Harriman & Co's Collegium Pharmaceutical position peaked at $11.3K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.